Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Experimental Medicine|October 29, 2008
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RATakuji Suzuki, Takuro Sakagami, Bruce K Rubin, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk FactorsGrant S Schulert, Shima Yasin, Brenna Carey, et al.
Human Gene Therapy|May 26, 2011
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim resultsTerence R Flotte, Bruce C Trapnell, Margaret Humphries, et al.
The Lancet. Rheumatology|March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trialPaul C Cremer, Antonio Abbate, Kristin Hudock, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 12, 2020
Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epitheliaKristin M Hudock, Margaret S Collins, Michelle Imbrogno, et al.
Annals of the American Thoracic Society|August 2, 2017
An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory DiseasesArnold S Kristof, Basil J Petrof, Qutayba Hamid, et al.
The European Respiratory Journal|August 15, 2024
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosisCormac McCarthy, Francesco Bonella, Marissa O'Callaghan, et al.
American Journal of Respiratory and Critical Care Medicine|May 30, 2013
Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012Michael A Matthay, Piero Anversa, Jahar Bhattacharya, et al.
The New England Journal of Medicine|August 20, 2025
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisBruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, et al.
Pageof 11